Chemo-Free hope: new cocktail targets aggressive lymphoma
Disease control
Not yet recruiting
This study tests a chemotherapy-free combination of three drugs (glofitamab, polatuzumab vedotin, and zuberitamab) in 40 adults with newly diagnosed diffuse large B-cell lymphoma. The goal is to see how well the treatment shrinks tumors and how safe it is. Participants must have …
Phase: PHASE2 • Sponsor: Li Zhiming • Aim: Disease control
Last updated May 01, 2026 15:57 UTC